Company Overview

Update
Founded:
2013
Founders:
Craig M. Crew
Headquarters:
New Haven, CT
Funding:
$15M
Categories:
Biotechnology
Description:
Arvinas is a pharmaceutical company focused on protein degradation approaches to develop novel drugs to treat cancer and other diseases.

Detailed Description

Update

Arvinas is a pharmaceutical company focused on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, autoimmune and rare diseases. Central to Arvinas’ proprietary approach is the targeting of disease-causing proteins for degradation thus eliminating them from the body. This strategy of degradation versus protein inhibition holds several advantages including the potential to target proteins that are not currently ‘druggable’ using a small molecule approach.

Current Team (2)

Update

Board Members and Advisors (2)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    5 SCIENCE PARK

    395 WINCHESTER AVENUE

    New Haven, CT 06511

    USA

Images (1)

Update
  • 451b86d054a35200a4e7d57b0380893c